OpenAI and Molecule.one have collaborated to develop a new AI system, powered by GPT-5.4, that has demonstrated significant progress in automating drug discovery. The AI agent, integrated with an automated laboratory, was able to propose and execute experiments to improve a common reaction in drug synthesis, specifically the Chan-Lam coupling. While the AI made key research decisions and designed experiments, human chemists provided high-level guidance, validated results, and performed critical experimental steps, indicating a "nearly autonomous" rather than fully autonomous process. AI
IMPACT This development signals a significant step towards AI-driven scientific discovery, potentially accelerating the pace of drug development and research across various fields.
RANK_REASON The item describes a research milestone where an AI model was used to improve a scientific process, with a focus on the AI's capabilities and limitations in a research context. [lever_c_demoted from research: ic=1 ai=1.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
